| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −2.5× | −1.7× | |
| Price / Book | 1.3× | 2.0× | |
| Price / Sales | 0.8× | 4.0× | |
| Price / Free cash flow | −6.4× | −1.5× | |
| EV / EBITDA | −7.2× | −1.2× | |
| Earnings yield | −39.2% | −14.3% | |
| Free cash flow yield | −15.7% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,296.37 | +4.52% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.08 | +2.08% | $624.36B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $289.95 | +2.57% | $512.38B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $421.31 | +3.55% | $378.17B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $147.95 | +3.01% | $365.02B | 19.4× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.41 | +2.14% | $282.81B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.79 | +2.95% | $261.78B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $688.38 | +1.32% | $254.53B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.35 | +2.45% | $235.36B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.53 | +1.60% | $192.84B | 22.3× | 37.5% | +29.9% |
